Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Medicis Solves One Solodyn Problem But Barr Pops Up With Another
- Barr Pharmaceuticals has filed to make a generic version of Medicis's acne drug, Solodyn. Medicis stock had received a nice boost at the beginning of December when it announced an unexpected deal with a different company, Impax, over generic versions of Solodyn. The deal meant Medicis would...
- Blog posts 2008-12-30
- The Pfizer-Shire Deal Worst-Case Scenario
- Earlier this week shares of Shire rose on rumors that Pfizer may be interested in acquiring the company, which is best-known for its ADHD drug Adderall XR. The notion that Pfizer is in acquisition mode has been driving people crazy for days. (See BNET's coverage of Pfizer Pfever here.) ...
- Blog posts 2009-01-07
Additional Resources
- Merger Watch: Barr Pharmaceuticals - Teva Pharmaceutical
- The M & A Researcher submits: First, this August 14 Financial Times article will be referenced as it essentially echoes this publication's original assessment of the Barr Pharmaceuticals BRL - Teva Pharmaceutical TEVA transaction upon announcement last month. Of particular interest in this piece are the following passages from...
- External links 2008-08-22
- Aventis, Barr Battle Over Generic Allegra.(Barr Laboratories, Aventis Pharma)(Brief Article)
- BARR LABORATORIES Inc. plans to challenge the patents protecting Allegra fexofenadine, the anti-allergy drug by Aventis Pharma AG. The action follow Barr's filing of an abbreviated new drug application ANDA with the Food & Drug Administrati BARR LABORATORIES Inc. plans to challenge the patents...
- Research articles 2001-07-09
- Barr & Barr: A MAJOR PLAYER In New Jersey
- Barr & Barr, Inc., the prominent construction manager building throughout the Metro area and the entire Northeast, has had a significant presence in New Jersey for more than 20 years. The firm's position in the Garden State was strengthened even more in 2000 with the purchase of a long-time...
- Research articles 2003-10-01
- Barr & Barr renovates Princeton center
- Barr & Barr, Inc., a New York City-based construction firm, recently completed the renovation of the landmark Frist Campus Center at Princeton University. The project involved renovation and restoration of the historic 110,000 SF building and construction of a brand-new 90,000 SF addition to the property. Barr & Barr...
- Research articles 2001-03-21
- Milacron, Barr making injection feed screws.(News)(Brief Article)
- Milacron Inc. has partnered with Barr Inc. of Virginia Beach, Va., to manufacture and sell Barr's injection feed screws in the United States. Officials announced the partnership during Plastics Encounter Southeast, held Oct. 18-20 in Charlotte. Milacron Inc. has partnered...
- Research articles 2005-11-07
- DUPONT Pharmaceuticals.(signs agreement with Barr Laboratories)(Brief Article)
- DUPONT Pharmaceuticals and Barr Lab-oratories have signed a development and marketing agreement under which DuPont will invest up to $45 ... DUPONT Pharmaceuticals and Barr Lab-oratories have signed a development and marketing agreement under which DuPont will invest up to $45 million to...
- Research articles 2000-03-27
- Barr, Mylan Report Strong Quarterly Results.(Barr Laboratories)(Brief Article)(Statistical Data Included)
- BARR LABORATORIES Inc. reported solid first quarter fiscal 2002 earnings, beating analysts' estimates on sales of its generic Prozac fluoxetine and breast cancer drug tamoxifen. Barr completed its merger with Duramed Pharmaceuticals Inc., accretive to 2003, which also reported solid third quarter earnings. ...
- Research articles 2001-10-29
- Hageman joins Famous-Barr as chairman. (James A. Hageman, department store Famous-Barr)
- HAGEMAN JOINS FAMOUS-BARR AS CHAIRMAN ST. LOUIS -- James A. Hageman has joined Famous-Barr, a division of May Department Stores Co., as chairman. Robert E. Friedman continues as president and chief executive officer of the St. Louis-based division. ...
- Research articles 1990-04-03
- Macho joins Famous-Barr as v-p. (Jeff Macho)
- Macho Joins Famous-Barr as V-P NEW YORK--Jeff Macho has joined Famous-Barr in St. Louis as divisional vice-president and divisional merchandise manager of young men's, boys' and men's tailored sportswear. He reports to Dennis Johnson, senior vice-president and general merchandise manager...
- Research articles 1988-09-07
- FAMOUS-BARR PICKS PICKELL AS PRESIDENT.
- ST. LOUIS-Ira Pickell was named president and chief executive officer of Famous-Barr, a division of May Department Stores Co. John Danahy remains chairman of Famous-Barr, headquartered here. "We are very pleased to have an executive with Ira's exceptional talent and experience joining May...
- Research articles 2000-09-11
- Bristol-Myers untangles Barr-DuPont agreements. (Partnerships).(Brief Article)
- Barr Laboratories (Pamona, NY) says it has reached a deal with Bristol-Myers Squibb to restructure a product development agreement and two marketing agreements that were forged between Barr and DuPont Pharmaceuticals, settling an anti-trust suit brought by Barr against DuPont in March 2000. Bristol-Myers purchased DuPont's...
- Research articles 2002-05-08
- Edward E. Barr to retire as chairman, Sun Chemical Group; Wes Lucas named chairman
- Edward E. Barr has announced his intention to retire as chairman, Sun Chemical Group B.V, on Jan. 1, 2003. Mr. Barr will be succeeded as chairman by Wes Lucas, Sun Chemical's president and CEO. Mr. Barr will continue as Sun Chemical's designated senior director of Kodak Polychrome Graphics, the company's...
- Research articles 2002-11-01
- An industry giant retires: after more than 40 years at Sun Chemical, Edward E. Barr to step down as chairman
- To say that Edward E. Barr is a seminal figure in the printing ink industry is an understatement. When Mr. Barr joined Sun Chemical in 1962, the company had annual sales of $25 million in ink and pigments. In 2001, Sun Chemical's ink and pigment sales were $3.5 billion. ...
- Research articles 2002-12-01
- Intuit executive named to IRS Information Reporting Program Advisory Committee; Robert E. Barr seeks to eliminate electronic filing "paperwork"
- MENLO PARK, Calif.--BUSINESS WIRE--Dec. 12, 1994--Intuit Inc. (NASDAQ:INTU), the nation's leading publisher of personal and small business finance and tax software, has announced that Robert E. Barr, vice president of electronic services, has been named by the Internal Revenue Service IRS to serve on the IRS's 1995-1996 Information Reporting Program...
- Research articles 1994-12-12
- Barr's generic warfarin is called interchangeable: FDA backs generics by writing a letter to medical groups.(Barr Laboratories, Food and Drug Administration)
- FDA backs generics by writing a letter to medical groups. An independent clinical trial published last week confirms the interchangeability of Barr Laboratories' generic warfarin sodium for DuPont Merck's Coumadin...
- Research articles 1998-02-09
- Ailing Barr can't help out needy ABC Family.(ABC Family has to pull plug on Roseanne Barr's "The Domestic Goddess" after she announces indefinite delay due to hysterectomy)
- ABC Family will continue to search for a buzz-building, network-transforming series, as a highly publicized cooking show featuring Roseanne Barr fell out of the oven last week. Industry observers called the canceling of The Domestic Goddess H ABC...
- Research articles 2003-08-25
- GENERICS.(Barr Laboratories , Ivax Corp. receive approval for flutamide product)(Brief Article)
- GENERICS companies Barr Laboratories and Ivax Corp. have received FDA approval for 125 mg flutamide capsules, the equivalent of ... GENERICS companies Barr Laboratories and Ivax Corp. have received FDA approval for 125 mg flutamide capsules, the equivalent of Schering Corp.'s Eulexin. A shareholder...
- Research articles 2001-10-01
- Leerink Swann & Company Initiates Coverage of Barr Pharmaceuticals, Inc. (NYSE: BRL) Mylan Laboratories Inc. (NYSE: MYL)
- This morning, Senior Generic Pharmaceutical Analyst, William F. Sawyer, initiated coverage of Barr Pharmaceuticals (NYSE: BRL) with an Outperform rating and Mylan Laboratories Inc. (NYSE: MYL) with a Market Perform rating. He bases his investment rating for Barr on his view that solid operating performance from Barr's generic and branded...
- Research articles 2005-12-16
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
